Thyroid toxicity as predictor of response to immunotherapy in lung cancer

被引：0
|
作者：
Kazanietz, V. [1 ]
Cayol, F. [1 ]
Cerini, M. [1 ]
Storino, J. [1 ]
Specterman, S. [1 ]
机构：
[1] Hosp Italiano Buenos Aires, Oncol, Buenos Aires, DF, Argentina
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.1186
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1066P
引用
收藏
页码：S725 / S725
页数：1
相关论文
共 50 条
  • [31] Frizzled 9 as a Predictor of Response to Iloprost Chemoprevention of Lung Cancer
    Tennis, Meredith
    Merrick, Daniel T.
    Nield, Lori
    Keith, Robert L.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S301 - S301
  • [32] Macroscopic extranodal extension is an independent predictor of lung metastasis in papillary thyroid cancer
    Hei, Hu
    Gong, Wenbo
    Zheng, Chen
    Zhou, Bin
    Qin, Jianwu
    ENDOCRINE, 2022, 77 (01) : 73 - 79
  • [33] Macroscopic extranodal extension is an independent predictor of lung metastasis in papillary thyroid cancer
    Hu Hei
    Wenbo Gong
    Chen Zheng
    Bin Zhou
    Jianwu Qin
    Endocrine, 2022, 77 : 73 - 79
  • [34] A retrospective analysis of eosinophilia as a predictive marker of response and toxicity to cancer immunotherapy
    Krishnan, Tharani
    Tomita, Yoko
    Roberts-Thomson, Rachel
    FUTURE SCIENCE OA, 2020, 6 (10):
  • [35] Circulating Biomarkers of Response and Toxicity of Immunotherapy in Advanced Non-Small Cell Lung Cancer (NSCLC): A Comprehensive Review
    Indini, Alice
    Rijavec, Erika
    Grossi, Francesco
    CANCERS, 2021, 13 (08)
  • [36] Candidate Biomarker of Response to Immunotherapy In Small Cell Lung Cancer
    Shen, Yili
    Liu, Zhicong
    Chen, Yi
    Shi, Xuefei
    Dong, Shunli
    Wang, Bin
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2025, 26 (02) : 73 - 83
  • [37] Tumor inflammatory signature as a biomarker of response to immunotherapy in lung cancer
    Pabla, Sarabjot
    Van Roey, Erik
    Conroy, Jeffrey M.
    Glenn, Sean
    Wang, Yirong
    Nesline, Mary
    Burgher, Blake
    Giamo, Vincent
    Andreas, Jonathan
    Lenzo, Felicia L.
    Morrison, Carl
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (05)
  • [38] Airway Fusobacterium is Associated with Poor Response to Immunotherapy in Lung Cancer
    Chu, Shujuan
    Cheng, Zaixing
    Yin, Zhongyuan
    Xu, Juanjuan
    Wu, Feng
    Jin, Yang
    Yang, Guanghai
    ONCOTARGETS AND THERAPY, 2022, 15 : 201 - 213
  • [39] The Importance of Imaging Studies in the Assessment of Response to Immunotherapy in Lung Cancer
    Gorospe, Luis
    Eduardo Pacios-Blanco, Ruben
    Garrido-Lopez, Pilar
    ARCHIVOS DE BRONCONEUMOLOGIA, 2020, 56 (06): : 380 - 389
  • [40] Prolonged response with paclitaxel after immunotherapy by pembrolizumab in lung cancer
    Zapata, E.
    Mennecier, B.
    Leduc, C.
    Chatron, E.
    Quoix, E.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2016, 72 (05) : 300 - 304
12345